FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on January 03, 2006

vaccine manufacturing facility in England, enabling them to to produce up to 15 million bulk doses per month, or approximately 90 million bulk doses per influenza manufacturing season, of its trivalent, intranasal influenza vaccine, FluMist (Influenza Virus Vaccine Live, Attenuated).Additionally, the plant will be used to manufacture its investigational flu vaccine, CAIV-T, as well as year-round vaccine production in case of a flu pandemic.
Source: MedImmune
Permalink: FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility
Tags:
flu vaccine biotech influenza manufacturing influenza+vaccine vaccine+manufacturing manufacturing+fa
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/13162






